• Something wrong with this record ?

U koho, kdy a jak upravovat srdeční frekvenci při fibrilaci síní
[Who, when and how to rate control for atrial fibrillation]

Michiel Rienstra, Isabelle C. Van Gelder

Language Czech Country Czech Republic

The aim of this review is to provide a perspective on rate control in atrial fibrillation, in the era after the large randomized trials comparing rate and rhythm control. This review emphasizes the indications for rate control, the optimal heart rate and the different treatment modalities. RECENT FINDINGS: Large studies have shown that rate control is not inferior to rhythm control with regard to cardiovascular morbidity and mortality. Rate control may now be instituted earlier during the course of the disease, even as first-choice therapy in some patients, particularly those with hypertension and underlying heart diseases, and those who are not (severely) symptomatic. The goals of rate-control therapy are to reduce symptoms, improve quality of life, minimize the development of heart failure, and prevent thromboembolic complications. An important negative aspect of rate-control therapy is the side effects of drugs. The optimal heart rate during atrial fibrillation has not yet been carefully investigated. Several approaches to control rate during atrial fibrillation are available, including pharmacological rate control and atrioventricular nodal ablation with pacemaker implantation. SUMMARY: Understanding the indications for rate control, treatment goals and options will gain the largest benefit for the individual patient with atrial fibrillation.

Who, when and how to rate control for atrial fibrillation

Bibliography, etc.

Lit.: 42

000      
02961naa 2200385 a 4500
001      
bmc07506299
003      
CZ-PrNML
005      
20111210122551.0
008      
080704s2008 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Rienstra, Michiel
245    10
$a U koho, kdy a jak upravovat srdeční frekvenci při fibrilaci síní / $c Michiel Rienstra, Isabelle C. Van Gelder
246    11
$a Who, when and how to rate control for atrial fibrillation
314    __
$a Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen
504    __
$a Lit.: 42
520    9_
$a The aim of this review is to provide a perspective on rate control in atrial fibrillation, in the era after the large randomized trials comparing rate and rhythm control. This review emphasizes the indications for rate control, the optimal heart rate and the different treatment modalities. RECENT FINDINGS: Large studies have shown that rate control is not inferior to rhythm control with regard to cardiovascular morbidity and mortality. Rate control may now be instituted earlier during the course of the disease, even as first-choice therapy in some patients, particularly those with hypertension and underlying heart diseases, and those who are not (severely) symptomatic. The goals of rate-control therapy are to reduce symptoms, improve quality of life, minimize the development of heart failure, and prevent thromboembolic complications. An important negative aspect of rate-control therapy is the side effects of drugs. The optimal heart rate during atrial fibrillation has not yet been carefully investigated. Several approaches to control rate during atrial fibrillation are available, including pharmacological rate control and atrioventricular nodal ablation with pacemaker implantation. SUMMARY: Understanding the indications for rate control, treatment goals and options will gain the largest benefit for the individual patient with atrial fibrillation.
650    _2
$a antiarytmika $x terapeutické užití $7 D000889
650    _2
$a fibrilace síní $x farmakoterapie $x chirurgie $x terapie $7 D001281
650    _2
$a nodus atrioventricularis $x chirurgie $7 D001283
650    _2
$a kardiostimulace umělá $7 D002304
650    _2
$a katetrizační ablace $7 D017115
650    _2
$a lidé $7 D006801
650    _2
$a výběr pacientů $7 D018579
700    1_
$a Van Gelder, Isabelle C.
773    0_
$w MED00156016 $t Current opinion in cardiology $g Roč. 2, č. 1 (2008), s. 21-25 $x 1802-3711
910    __
$a ABA008 $b B 2480 $c 414 $y 1
990    __
$a 20080704081217 $b ABA008
991    __
$a 20080708085810 $b ABA008
999    __
$a ok $b bmc $g 621925 $s 474358
BAS    __
$a 3
BMC    __
$a 2008 $b 2 $c 1 $d 21-25 $i 1802-3711 $m Current opinion in cardiology (České vyd.) $x MED00156016
LZP    __
$a 2008-7/mkme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...